Safety and Efficacy of an Oxytocin Gel and an Equivalent Gel but Without Hormonal Ingredients (Vagivital(®) Gel) in Postmenopausal Women with Symptoms of Vulvovaginal Atrophy: A Randomized, Double-Blind Controlled Study

PURPOSE: The primary objective was to compare the efficacy of 12 weeks of daily treatment with Aqueous Hypromellose-based vaginal (Vagivital(®)) gel versus Aqueous Hypromellose-based vaginal gel plus 400 IU oxytocin gel in reducing the severity of the most bothersome vulvovaginal atrophy symptoms (M...

Descripción completa

Detalles Bibliográficos
Autores principales: Fianu Jonasson, Aino, Bixo, Marie, Sundström Poromaa, Inger, Åstrom, Mikael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547122/
https://www.ncbi.nlm.nih.gov/pubmed/33116956
http://dx.doi.org/10.2147/MDER.S265824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547122/
https://www.ncbi.nlm.nih.gov/pubmed/33116956
http://dx.doi.org/10.2147/MDER.S265824

Ejemplares similares